| ［1］ Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypesdealing with the diversity of breast cancer: highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011［J］. Ann Oncol, 2011, 22(8): 1736-1747. ［2］ Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer ［J］. J Clin Oncol, 2010, 28(16): 2784-2795. ［3］ Guideline Recommendations for HER2 Detection in Breast Cancer Group. Guidelines for HER2 detection in breast cancer, the 2009 version［J］. Zhonghua Bing Li Xue Za Zhi, 2009, 38(12): 836-840. ［4］ Donsett M, Nielsen TO, A Hern R, et al. Assessment of Ki67 in breast cancer:recommendations from the International Ki67 in Breast Cancer working group［J］. Natl Cancer Inst, 2011, 103(22): 1656-1664. ［5］ Sorlie T, Peron CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications［J］. Proc Natl Acad Sci USA, 2001, 98(19): 10869-10874. ［6］ Peron CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours［J］. Nature, 2000, 406(6797): 747-752. ［7］ Zhao J, Liu H, Wang M, et al. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women［J］. J Surg Oncol, 2009, 100(2): 89-94. ［8］ 胡慧, 刘倩, 徐玲, 等. 乳腺癌临床病例分类与临床病理特征研究［J］. 中华外科杂志, 2014, 52(2):113-116. ［9］ Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifentreated, nodenegative breast cancer［J］. N Engl J Med, 2004, 351(27): 2817-2826. ［10］ BuenodeMesquita JM, van Harten WH, Retel VP, et al. Use of 70gene signature to predict prognosis of patients with nodenegative breast cancer:a prospective communitybased feasibility study (RASTER)［J］. Lancet Oncol, 2007, 8(12): 1079-1087. ［11］ Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013［J］. Ann Oncol, 2013, 24(9): 2206-2223. |
